Clinical Trial Update: DC1s-CTL Cellular Therapy for Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 clinical trial of DC1s-CTL cellular therapy for renal cell carcinoma, with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• DC1s-CTL Cellular Therapy

Snippet

Sponsor: Xuzhou Medical University | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN